ArticleCureus2026
Frequency and Severity of Diabetic Retinopathy in Patients With Diabetic Foot Ulcers at a Tertiary Hospital in Bangladesh.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Diabetic retinopathy (DR) and diabetic foot ulcers (DFUs) are major complications of type 2 diabetes mellitus (T2DM) that significantly contribute to morbidity, particularly in low- and middle-income countries such as Bangladesh. While DR is a leading cause of vision loss, DFU is a major contributor to lower-limb amputation. These complications may coexist as manifestations of systemic vascular damage. This study aimed to determine the frequency and severity of DR among patients with DFU and to evaluate its association with ulcer severity using Wagner's classification. Methodology This cross-sectional study was conducted from August 2021 to July 2022 at Sher-E-Bangla Medical College Hospital, Barishal, Bangladesh. A total of 100 adult patients with T2DM and Wagner-graded DFU were included using purposive sampling. Ophthalmologic evaluation included visual acuity assessment, slit-lamp biomicroscopy, dilated fundus examination, fundus photography, and optical coherence tomography. DR was graded according to the Early Treatment Diabetic Retinopathy Study (ETDRS) classification, and DFU severity was assessed using the Wagner grading system. Laboratory parameters, including HbA1c, lipid profile, serum creatinine, and hemoglobin, were recorded. Statistical analysis was performed using SPSS version 23.0, with chi-square tests applied to assess associations (p < 0.05 considered significant). Results The mean age of participants was 55.7 ± 10.9 years, and 67 (67%) patients were male. DR was present in 80 (80%) patients, with mild non-proliferative diabetic retinopathy (NPDR) being the most common subtype in 36 (36%) patients, followed by severe NPDR in 21 (21%) patients, moderate NPDR in 14 (14%) patients, proliferative diabetic retinopathy (PDR) in 9 (9%) patients, high-risk PDR in 3 (3%) patients, and advanced diabetic eye disease in 6 (6%) patients. Visual impairment (≤6/60) was observed in 33 (33%) patients in the right eye and 36 (36%) patients in the left eye. A significant association was found between DR severity and higher Wagner grades of DFU (p = 0.001). Patients with DR had a longer duration of diabetes (15.3 ± 6.6 vs. 9.7 ± 4.5 years, p = 0.006), were more likely to smoke (31 patients, 38.8% vs. 0 patients, 0%; p = 0.018), and had lower hemoglobin levels (10.9 ± 1.8 vs. 12.1 ± 1.1 g/dL, p = 0.046). Conclusion DR is highly prevalent among patients with DFUs, with severity closely associated with ulcer grade. These findings support the need for routine ophthalmologic screening in patients presenting with DFU and highlight the importance of integrated care to reduce the risk of both vision loss and limb amputation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.